United States: US Department Of Health And Human Services Issues Final "Sunshine" Rule Imposing Reporting Requirements On Payments To Physicians And Teaching Hospitals

Keywords: Sunshine rule, reporting requirements, payments, teaching hospitals, group purchasing organizations, GPOs

The Centers for Medicare & Medicaid Services (CMS) has announced a final rule that will implement section 1128G of the Social Security Act, as added by section 6002 of the Affordable Care Act. The new rule will impose reporting requirements on manufacturers of drugs, devices, and biological or medical supplies, as well as on group purchasing organizations (GPOs) concerning certain financial dealings with physicians and teaching hospitals. Organizations must begin collecting data for the new reports on August 1, 2013.

Two Forms of Annual Reporting

Under the new rule, applicable manufacturers must report annually to the Health and Human Services (HHS) Secretary all payments or other transfers of value given to physicians or teaching hospitals. In addition, applicable manufacturers and applicable GPOs must report ownership and investment interests held by physicians or their immediate family members.

Only Manufacturers and GPOs Must Report; Physicians and Teaching Hospitals Should Monitor Submissions

The new rule will apply to manufacturers of drugs, devices and biological and medical supplies that are covered by Medicare, Medicaid, or CHIP. The requirements apply only to manufacturers operating in the United States: that have a physical location in the United States (including territories, possessions, or commonwealths) or that otherwise conduct activities within the United States, either directly or through an agent.

Distributors and wholesalers are excluded from the requirement, so long as they do not hold title to any covered drug, device, or biological or medical supply. However, an entity that is under common ownership with an applicable manufacturer, and that provides services relating to the covered items, will be required to make reports.

Similarly, GPOs are subject to the rule if they operate in the United States and purchase or otherwise arrange for or negotiate the purchase of a covered drug, device, or biological or medical supply for a group of individuals or entities. If the purchase is solely for use by the entity, the reporting requirement is not triggered.

Physicians and teaching hospitals are not required to make the reports, but they should remain attentive to the new process in order to ensure the accuracy of any reports relating to them. Physicians and hospitals should consider registering with CMS in order to receive notification when new reports are available for review.

Form of Reports

Manufacturers will be required to report all payments or other transfers of value that they give to physicians or teaching hospitals, including consulting fees, compensations for services other than consulting, honoraria, gifts, entertainment, food and beverage, travel and lodging, education, research, charitable contributions, royalties or licenses, current or prospective investment or ownership interests, faculty or speaker compensation, grants, and space rentals. Third-party payments must be included in the reports as well. For example, a manufacturer must report a payment by a third party to a physician if that payment was made at the manufacturer's behest. Similarly, manufacturers must report a payment that was made to a third-party recipient at the request of, or on behalf of, a physician.

Payments under $10 are excluded from reporting, unless the aggregate transfer to a given recipient exceeds $100 in a calendar year. (This de minimus exclusion will increase with inflation in future years.) The rule also excludes a variety of other defined transfers, including samples and demonstratives intended for patient use only, in-kind items used for the provision of charity care, payments to employees and their families for healthcare expenses, and dividends or profits from ownership interests. Along with identifying information such as the date and recipient, the report must include the amount, form, and nature of the payment or transfer and must identify the covered drug, device or biological or medical supply to which it relates, if applicable. In addition, CMS' final rule accedes to public comment that had requested that manufacturers and GPOs be allowed to submit brief explanations of the context of the physician and hospital payments. In many cases, it may be to a manufacturer's benefit to include this additional information. These context explanations will be included in the public posting.

The ownership and investment interests reports will provide identifying information concerning the physician or family member, as well as the dollar amounts invested and the value and terms of the ownership or investment interests. "Ownership or investment interests" encompasses both direct and indirect interests, including stock and stock options, partnership shares, limited liability company membership, and loans, bonds, or other secured financial instruments. Interests in a publicly traded security or mutual fund are excluded, as are certain other defined interests, including those interests about which the manufacturer or GPO did not know.

Each report must be accompanied by an attestation from the Chief Executive Officer, Chief Financial Officer, Chief Compliance Officer, or other officer that the information reported is timely, accurate, and complete to the best of his or her knowledge or belief. An organization may also submit an "assumptions" document, explaining the reasonable assumptions made and methodologies used when creating the report. Assumptions documents will not be made public, but may be used by CMS to refine the reporting system.

Information Will Be Publicly Posted

The data collected from manufacturers and GPOs will be shared with the public via website posting in a format designed to facilitate aggregation, downloading, and searching. The rule allows for delayed posting of certain payments made in connection with research and development activities—including clinical trials—that may warrant confidential treatment. Before the information is released to the public, physicians, hospitals, manufacturers, and GPOs will be afforded at least 45 days to dispute and correct the reported information. CMS will make online postings when the information is available for review. Physicians and teaching hospitals may also register with CMS to receive notification about the review process.

Data Collection Commences August 1, 2013; Reports Follow on March 31, 2014

Covered manufacturers and GPOs must begin collecting data relating to their physician payments and physician ownership/investment interests on August 1, 2013. The data for the initial August-December 2013 time period must be reported to HHS by March 31, 2014. CMS intends to release this first data set by September 30, 2014.

Thereafter, reporting will continue on an annual basis. Entities must register with CMS and make their reports within 90 days of the end of the calendar year for which the report is required.

Audit Authority and Penalties For Failure To Report

Pursuant to the Affordable Care Act, companies that fail to report under these new requirements will be subject to civil fines of between $1,000 and $10,000 for each payment, transfer of value, or ownership or investment interest not timely and accurately reported, with the annual total penalty capped at $150,000 for each manufacturer or GPO. For knowing failure to report, the penalty increases to $10,000-$100,000 per instance, capped at $1 million annually.

Applicable manufacturers and GPOs are subject to audit or inspection by the HHS Office of Inspector General and the CMS. To facilitate the inspections, manufacturers and GPOs will now be required to maintain relevant records and documents for at least five years.

State Law Preempted

Pursuant to the Affordable Care Act, no state or local government may require separate reporting of the information required by the new rule, unless the information is being collected by a governmental agency for public health surveillance, investigation, or other public health or oversight purposes.

Originally published on February 13, 2013

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2013. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Drinker Biddle & Reath LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Drinker Biddle & Reath LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions